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Abstract
Due to the recent gains in the availability of single-nucleotide polymorphism data, genome-wide
association testing has become feasible. It is hoped that this additional data may confirm the
presence of disease susceptibility loci, and identify new genetic determinants of disease. However,
the problem of multiple comparisons threatens to diminish any potential gains from this newly
available data. To circumvent the multiple comparisons issue, we utilize a recently developed
screening technique using family-based association testing. This screening methodology allows for
the identification of the most promising single-nucleotide polymorphisms for testing without
biasing the nominal significance level of our test statistic. We compare the results of our screening
technique across univariate and multivariate family-based association tests. From our analyses, we
observe that the screening technique, applied to different settings, is fairly consistent in identifying
optimal markers for testing. One of the identified markers, TSC0047225, was significantly
associated with both the ttth1 (p = 0.004) and ttth1-ttth4 (p = 0.004) phenotype(s). We find that
both univariate- and multivariate-based screening techniques are powerful tools for detecting an
association.
Background
Over the last few years, the field of statistical genetics has
been the subject of challenging and exciting evolutions. As
a result of human genetic sequencing, not only has data
quality improved substantially, but the sheer volume of
available data has vastly increased. The success of
genome-wide association studies will depend upon
whether the increase in numbers of single-nucleotide pol-
ymorphisms (SNPs) can be translated into an increase in
the overall power to detect genotype × phenotype associ-
ations, or whether this potential increase in power will be
diluted by the problem of multiple comparisons. In Van
Steen et al. [1], the authors proposed that the multiple
comparisons issue in genome × wide association testing
could be addressed using the screening tools initially
developed by Lange et al. [2,3]. This screening methodol-
ogy finds the genotype × phenotype combinations with
the most power to detect an association, without biasing
any subsequently computed test statistic. In our paper, we
apply this methodology, using the software package PBAT
(pedigree-based association testing) [4] to sift through
SNP data from the Collaborative Study on the Genetics of
Alcoholism (COGA).
Methods
Dataset
In our analysis, the data was restricted to the genotypes
from the Affymetrix SNP panel. This SNP data, along with
from Genetic Analysis Workshop 14: Microsatellite and single-nucleotide polymorphism
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quantitative trait information for approximately 1,613
subjects, comprised our dataset. The 1,613 subjects come
from 143 families, with a mixture of large and small ped-
igrees. Using chromosome 4 as a template for the
genome-wide screening techniques, we investigate the
association between the 786 Affymetrix SNPs on chromo-
some 4, and the four measures corresponding to the "late"
time window from the Visual Oddball Experiment, ttth1-
ttth4. These four measurements correspond to electrode
placements on the midline, central midline, and parietal
midline channels, respectively. The phenotypes were
transformed to standard normal scores for the analysis.
While there appears to be no documented research sup-
porting an association between chromosome 4 (or
another chromosomal regions) and the "late" time win-
dow measurements, several studies have proposed a
region of linkage for the electroencephalogram (EEG)
phenotype on chromosome 4 [5-7]. Furthermore, EEG
demonstrates some correlation with the ttth phenotypes,
r = 0.11, 0.18, 0.26, 0.25 for measurements 1–4, respec-
tively. The correlation between the four "late" window
measurements ranges from 0.54 (ttth1 and ttth3) to 0.91
(ttth3 andttth4). Our goal was to conduct both univariate
and multivariate (with related traits) analyses on a chro-
mosome with regions suggestive of linkage, and contrast
these methods in the context of genomic screening.
Because no candidate chromosomes have been suggested
for these jointly modelled phenotypes, we opted to use
chromosome 4 as a template due to some replication of
linkage findings for EEG [5-7] and its association with the
ttth phenotypes.
FBAT: Background and univariate test statistic
In the first stage of the analysis, we apply our screening
technique in a univariate setting to investigate family-
based associations with the far frontal left side channel
measurements (ttth1). The family-based association test
(FBAT) statistic [8] comprises a linear combination of
observed offspring genotypes and traits. The test statistic is
defined as: S = ∑ij TijXij, where Xij denotes a coding of the
marker genotype of the jth offspring in family i. The coded
trait of the jth offspring in the ith family is defined by Tij. In
general, the trait will be mean-centered. The test statistic,
a score function, in large samples is defined as: Z = ∑ij
Tij(Xij  -  E(Xij))/Var(S)1/2  ~  N(0,1), where E(Xij) is the
expected value of the coding function for the offspring
genotype, conditional on the parental genotype and
parental/offspring phenotypes, which are assumed to fol-
low Mendelian segregation under the null hypothesis.
This methodology extends readily to scenarios in which
the parental genotypes are not known, using the approach
of Rabinowitz and Laird [9]. The FBAT statistic has an
additional advantage in that it is robust against popula-
tion admixture and stratification [9].
PBAT: Screening methodology
The screening technique proposed by Lange et al. [2] iden-
tifies the markers with the highest conditional power [10]
without biasing any subsequent test statistic. First, a set of
phenotypes (or phenotype) are selected. A model that
describes the phenotypes as a function of the genotypes is
chosen. When conducting the screening process for the
most powerful SNPs for this set of phenotypes, the
observed offspring genotypes are replaced by the expected
offspring genotypes, conditional on the parental geno-
types or sufficient statistics [9]. (The use of the observed
genotypes would bias the nominal significance level of
the FBAT statistic). This adjusted model is used in estimat-
ing effect-size parameters for the genetic model. Lastly,
using the conditional power calculations described in
Lange and Laird [10], the power for each SNP-trait combi-
nation is estimated. The subset of SNPs with the highest
conditional power may be selected and their p-values
need only be adjusted according to the size of the selected
subset. This screening process is used in both a univariate
and multivariate setting. The process differs only in the
model that describes the phenotypes as a function of the
genotypes, and thus, how the effect-size estimates are gen-
erated (least-squares for univariate, principal components
analysis for FBAT-PC [11], and generalized estimating
equations for FBAT-GEE [12]. These test statistics and
screening methodologies are available in the PBAT soft-
ware package http://www.biostat.harvard.edu/~clange/
default.htm. The FBAT-PC and FBAT-GEE statistics are
briefly reviewed to provide a reference for the reader.
Please refer to the original published descriptions [11,12]
for further description.
FBAT: Two approaches to modelling multiple phenotypes
FBAT-PC
Using the four-electrode measurements ttth1-ttth4, we
construct the "generalized" principal component [11] that
maximizes heritability. Heritability is defined as the pro-
portion of the total variance attributable to the genetic
effect being tested. This methodology applies generalized
principal component analysis to both the phenotypic and
genetic variance matrices. This approach differs from
standardized generalized principal components analysis,
which only applies data reduction techniques to the phe-
notypic variance matrix. When multiple quantitative phe-
notypes are measured, a composite phenotype may be
constructed which amplifies the phenotype heritability by
aggregating the genetic components of all the traits into a
single phenotype with maximal heritability. Using the
univariate FBAT statistic [8] on this newly created compo-
nent, FBAT-PC, is particularly attractive, given that higher
heritabilities amount to the success of genome-wide asso-
ciation screening.BMC Genetics 2005, 6:S115
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FBAT-GEE
The four electrode measurements, ttth1-tth4, also may be
be tested simultaneously using the multivariate FBAT sta-
tistic (FBAT-GEE) of Lange et al. [12]. The FBAT-GEE sta-
tistic uses generalized estimating equations to analyze
multivariate data. The multivariate FBAT-GEE and its
validity do not require any assumptions for the pheno-
types. It allows for testing of different trait types (e.g., con-
tinuous or binary) without specifically modelling the
dependence of the multivariate traits on the genotype
information. Making effective use of all available trait
information, it often leads to increased power to detect
the alternative, as it allows for for fewer statistical compar-
isons by simultaneously testing phenotypes. This is also
an attractive methodology, given the increasingly com-
plex traits, such as alcoholism, currently under study.
Results
Univariate phenotype: ttth1
Table 1 displays the FBAT test results for ttth1 for five
marker-trait combinations with the highest power. The
top five power estimates range from 0.9985 to 0.9906.
However, the actual power estimates are somewhat arbi-
trary, because they are dependent upon the predeter-
mined alpha level of the FBAT statistic. Of greater
importance is the relative power of the SNP-phenotype
association, thus the five markers with the highest overall
power were selected. All available Affymetrix SNPs on
chromosome 4 were considered in the analysis. Markers
with significant Hardy-Weinberg tests (p-values < 0.05)
were removed, as an indication of genotyping error. Addi-
tionally, in genomic association screens, these raw results
can no longer be benchmarked against 0.05. For overall
significance, using a Bonferroni correction, a p-value <
0.01 is required, based upon the reporting of the top five
results by power estimate. One of the observed markers,
TSC0047225, demonstrates significant association, with a
p-value of 0.004.
Multiple phenotypes: ttth1-ttth4
FBAT-PC
Of the top five markers with the highest power in the uni-
variate analysis, four (TSC004275, TSC0045785,
TSC0570893, and TSC0518297) also have been identified
using the principal components statistic. The results are
shown in Table 2. Again, only one marker, TSC0047225,
achieves significance.
FBAT-GEE
Table 3 shows the results from the FBAT-GEE analysis.
Interestingly, only two of the five markers (TSC0047225
and TSC0518297) identified in the univariate analysis
were among the five demonstrating the most power for
this multivariate test. The FBAT-PC and FBAT-GEE results
shared only one common SNP (TSC0047225). However,
in comparison to both the FBAT and FBAT-PC statistics,
the observed significance level for both of these markers
increases. TSC0047225 is no longer significant at the 0.01
level, while marker TSC0518297 does not approach the
Table 1: FBAT results using ttth1
Marker Allele frequency Allele No. Informative 
families
p-Value FBAT Powera
TSC1091705 1 0.5581 44 0.2593 0.9985
TSC0047225 2 0.6268 47 0.0040 0.9964
TSC0149925 1 0.4551 42 0.0575 0.9948
TSC0274878 2 0.4111 42 0.0256 0.9908
TSC0518297 1 0.4477 38 0.8866 0.9906
Analysis restricted to additive genetic model.
aConditional power calculation for the FBAT test with alpha level 10-8.
Table 2: FBAT-PC results using ttth1-ttth4
Marker Allele Allele frequency No. Informative 
families
FBAT-PC Powera
TSC1091705 1 0.5581 44 0.2761 0.9991
TSC0274878 2 0.4111 42 0.0286 0.9984
TSC0047225 2 0.6268 47 0.0040 0.9975
TSC0149925 1 0.4551 42 0.1015 0.9965
TSC0059981 1 0.5495 38 0.4511 0.9914
Analysis restricted to additive genetic model.
aConditional power calculation for the FBAT test with alpha level 10-8.BMC Genetics 2005, 6:S115
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alpha level in either the univariate or multivariate analy-
sis.
Discussion
Using our screening techniques, we identified a SNP
(TSC004275) that is associated with the ttth1-ttth4 phe-
notypes. This SNP is located at approximately 133 cM on
chromosome 4. Concurrent and subsequent analyses will
determine whether this finding is supported via other
screening methodologies.
Overall, the analysis of these data, using both univariate
and multivariate analyses, highlights a key point. More
credibility maybe given to markers that are identified
through multiple screening techniques. TSC0047225 was
selected in all three analyses, and was significant in two of
the three (p = 0.004). The reason for the similarity in sig-
nificance levels in the FBAT and FBAT-PC analysis, and the
non-significance of the FBAT-GEE result may be due to
noise created by a particular phenotypic measurement, or
ttth1 maybe primarily responsible for the observed asso-
ciation seen in the univariate analysis. The similarity of
the FBAT and FBAT-PC results with regard to the identified
SNPs also are surprising, and suggest that the ttth1 pheno-
type may be driving the association. Those performing
future association analyses may want to utilize pheno-
types (such as ttth and ECB21 phenotype) that are not as
strongly correlated.
Alternatively, there may be an individual locus with plei-
otropic effects, and FBAT-PC may simply have more
power than FBAT-GEE to detect an association. Using sim-
ulated data, Lange et al. [11] demonstrated that FBAT-PC
has greater power than FBAT-GEE to detect a causal locus
when the phenotypes are highly correlated (r = 0.8) and
the heritability is constant across phenotypes. In the
FBAT-GEE results, the observed heritabilities (not shown)
were very similar (~0.4) across phenotypes, and 3 of the 4
ttth phenotypes are highly correlated. Thus, the data sug-
gest a scenario in which the FBAT-PC statistic is likely to
have greater power than FBAT-GEE. However, given the
similarity of the univariate FBAT and FBAT-PC results, this
hypothesis is less likely. Despite the similarity of the FBAT
and FBAT-PC results, analysis of multiple phenotypes can
be more powerful than that of single phenotypes when
attempting to unravel the genetic structure underlying
complex traits.
A final possibility is that there is no causal locus, and the
finding is spurious. Using any method for genome-wide
screening, this is always a possibility, especially when the
findings are not supported by other studies. However, the
paper by Van Steen et al. [1] demonstrated via simulation
studies that the nominal alpha levels are maintained
using these screening tools. Association testing for
genome-wide screening is novel, and more time is needed
to determine whether initial results will be replicated
using this testing methodology.
Conclusion
In this paper, we implemented a novel screening tech-
nique in the context of genome-wide association testing,
and contrasted the results of this screening methodology
across univariate and multivariate settings. Through this
analysis, it was suggested both univariate and multivariate
testing methodologies are useful in detecting genotype ×
phenotype associations. Additionally, multivariate meth-
ods can be powerful tools in finding associations that may
not be detectable in the univariate setting.
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